Trial Profile
Prevention of Colic With the Probiotic Lactobacillus Reuteri in Mexican Infants: Randomized, Double-blind Study
Status:
Not yet recruiting
Phase of Trial:
Phase II/III
Latest Information Update: 22 Jul 2022
Price :
$35
*
At a glance
- Drugs Limosilactobacillus reuteri (Primary)
- Indications Colic
- Focus Therapeutic Use
- 20 Oct 2015 New trial record